“… 78 , 79 , 80 , 81 More recently, a mechanism underlying this activity was unveiled in a study showing that GH signalling leads to WIP1-mediated suppression of the DDR pathway. 82 In the future, it would be interesting to explore the effect of either eliminating these GH-secreting senescent cells, and their SASP, or describing the effect of inhibiting their senescent program, both in somatotropinomas and other organs. Such studies would certainly provide important insights regarding the application of senotherapeutics in somatotropinoma management.…”